Spectrophotometric determination of some histamine H1-antagonists drugs in their pharmaceutical preparations.
Two rapid, simple and sensitive extractive specrophotometric methods has been developed for the determination of three histamine H1-antagonists drugs, e.g., chlorphenoxamine hydrochloride (CPX), diphenhydramine hydrochloride (DPH) and clemastine (CMT) in bulk and in their pharmaceutical formulations. The first method depend upon the reaction of molybdenum(V) thiocyanate ions (Method A) with the cited drugs to form stable ion-pair complexes which extractable with methylene chloride, the orange red color complex was determined colorimetrically at lambda(max) 470nm. The second method is based on the formation of an ion-association complex with alizarin red S as chromogenic reagents in acidic medium (Method B), which is extracted into chloroform. The complexes have a maximum absorbance at 425 and 426nm for (DPH or CMT) and CPX, respectively. Regression analysis of Beer-Lambert plots showed a good correlation in the concentration ranges of 5.0-40 and 5-70microgmL(-1) for molybdenum(V) thiocyanate (Method A) and alizarin red S (Method B), respectively. For more accurate analysis, Ringbom optimum concentration ranges were calculated. The molar absorptivity, Sandell sensitivity, detection and quantification limits were calculated. Applications of the procedure to the analysis of various pharmaceutical preparations gave reproducible and accurate results. Further, the validity of the procedure was confirmed by applying the standard addition technique and the results obtained in good agreement well with those obtained by the official method.
Hassan
Wafaa S
WS
Analytical Chemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, Egypt.
El-Henawee
Magda M
MM
Gouda
Ayman A
AA
D000880:Anthraquinones / Q000737:chemistry; D002974:Clemastine / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D004155:Diphenhydramine / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D004304:Dosage Forms; D005021:Ethylamines / Q000032:analysis / Q000737:chemistry / Q000302:isolation & purification; D006634:Histamine H1 Antagonists / Q000032:analysis* / Q000737:chemistry / Q000302:isolation & purification; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D004364:Pharmaceutical Preparations / Q000737:chemistry*; D015203:Reproducibility of Results; D012997:Solvents / Q000737:chemistry; D013053:Spectrophotometry; D013696:Temperature; D013997:Time Factors
D000880:Anthraquinones; D004304:Dosage Forms; D005021:Ethylamines; D006634:Histamine H1 Antagonists; D004364:Pharmaceutical Preparations; D012997:Solvents; C004468:Alizarin Red S; C100100:chlorphenoxamine; D004155:Diphenhydramine; D002974:Clemastine